Berberine improves DSS-induced colitis in mice by modulating the fecal-bacteria-related bile acid metabolism

• Published in: Biomedicine & pharmacotherapy 2023-11, Vol.167, p.115430-115430, Article 115430
• Main Authors: Sun, Xiongjie, Zhang, Yu, Cheng, Gang, Zhu, Tianxiang, Zhang, Zhigang, Xiong, Lei, Hu, Haiming, Liu, Hongtao
• Format: Article
• Language: English
• Subjects: Berberine; Gut microbiota; Intestinal metabolites, Bile acids; Ulcerative colitis
• ISSN: 0753-3322; 1950-6007
• DOI: 10.1016/j.biopha.2023.115430

Ulcerative colitis (UC) has been confirmed as a disease with a high incidence and low cure rate worldwide. In severe cases, UC can develop into colon cancer. Modern research has confirmed that berberine (BBR) can treat UC by inhibiting the expressions of inflammatory factors. However, the contribution of gut microbiota and flora metabolites in treating UC with BBR remains unclear. In this study, the ameliorative effects of BBR on gut microbiota dysbiosis and flora metabolites were investigated in a dextran sodium sulfate (DSS)-induced UC rodent model. We found that BBR significantly improved the pathological phenotype, attenuated intestinal barrier disruption, and mitigated colonic inflammation in DSS mice. By 16 S rDNA sequencing, BBR alleviated gut microbiota dysbiosis in UC mice. Moreover, the gut microbiota depletion experiment confirmed that the therapeutic effect of BBR was inextricably correlated with the gut microbiota. Besides, the flora metabolites (e.g., short-chain fatty acids, bile acids, and 5-hydroxytryptamine) were studied using HPLC-MS. The results suggested that BBR ameliorated the bile acid imbalance induced by DSS in the liver and gut. Furthermore, BBR treatment repaired gut barrier damage. The above results revealed that BBR alleviated DSS-induced UC in mice by restoring the disturbed gut microbiota, elevating unconjugated and secondary bile acids in the gastrointestinal tract, and activating the FXR and TGR5 signal pathway. This study provides novel insights into the mechanism of BBR in treating UC. [Display omitted] •Berberine suppressed colonic inflammation and increased gut barrier integrity.•Berberine reversed the imbalance of gut microbiota and bacterial metabolites.•Berberine regulated bile acid levels by increasing Lactobacillus and Roseburia.•Berberine modulated bile acid metabolism through activating FXR-TGR5 signaling.